ExactlyA full disclosure of:What additional funding is required...

Exactly

A full disclosure of:

• What additional funding is required outside existing cash reserves to complete the current construction to a point where ECT can produce a consumable product for market?
• When will ECT have consumable product ready to be sold to offtake companies?
• What potential types of offtake companies are in the mix to buy consumable product?
• What is the volume appetite in the current marketplace for consumption of the upcoming product?
• When will ECT sell enough consumable product in order to pay for production and running costs?
• What are the alternatives available to ECT if they cannot sell enough product to cover the ongoing production and running costs?
• How will ECT fund future plant and production developments?

This is at least where the real disclosure to shareholders and future investors must/should actually start.

"On the other hand, companies that do not provide these reports show a lack of transparency and concerned investors may overlook them as potential investments." thanks to an earlier posting.